14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today ADMP ranks #16122 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Adamis Pharmaceuticals Corporation Stock Forecast NASDAQ:ADMP

$0.72 (0.28%)

Volume: 978k

Closed: Dec 08, 2021

Hollow Logo Score: -4.139

Adamis Pharmaceuticals Corporation Stock Forecast

$0.72 (0.28%)

Volume: 978k

Closed: Dec 08, 2021

Score Hollow Logo -4.139
Which way will ADMP go? Request
Key Stats
P/E Ratio -2.03
Beta 1.39
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] The Adamis Pharmaceuticals Corporation stock currently holds an RSI14 at 21 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Green day on Wednesday for Adamis Pharmaceuticals Corporation
(Updated on Dec 08, 2021)

Sell candidate since 2021-12-08

The Adamis Pharmaceuticals Corporation stock price gained 0.28% on the last trading day (Wednesday, 8th Dec 2021), rising from $0.71 to $0.72. , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 3.45% from a day low at $0.71 to a day high of $0.73. The price has been going up and down for this period, and there has been a -11.34% loss for the last 2 weeks. Volume fell on the last day by -295 thousand shares and in total, 978 thousand shares were bought and sold for approximately $699.80 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.67 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -21.81% during the next 3 months and, with a 90% probability hold a price between $0.52 and $0.83 at the end of this 3-month period.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, December 03, 2021, and so far it has risen 4.91%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Adamis Pharmaceuticals Corporation stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.73 and $0.94. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss

Adamis Pharmaceuticals Corporation finds support from accumulated volume at $0.71 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0245 between high and low, or 3.45%. For the last week the stock has had a daily average volatility of 7.68%.

Adamis Pharmaceuticals Corporation is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Adamis Pharmaceuticals Corporation stock A Buy?

Adamis Pharmaceuticals Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.139

Predicted Opening Price for Adamis Pharmaceuticals Corporation of Thursday, December 9, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 9, 2021 Current price
$0.72 $0.72 (Undervalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

Maxim Group is very positive about ADMP and gave it a "Buy" rating on Sep 23, 2020. The price target was set to $1.50.

Volatility and Risk
Daily Average Volatility: 7.68 %
Overall Risk: Very High High Medium Low Very Low
7.68 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $0.73
Price: $0.72
Support: $0.71

ADMP Insider Trading Show all Trades



Last 100 transactions
Buy: 2 005 439 | Sell: 1 075 013 (Shares)
Date Action Amount Person Type
Dec 01, 2021 Sell 47 870 Carlo Dennis J Phd Common Stock
Dec 01, 2021 Sell 50 757 Marguglio David J. Common Stock
Dec 01, 2021 Sell 35 553 Moss Ronald B. Common Stock
Dec 01, 2021 Sell 13 554 Benedicto David C. Common Stock
Oct 01, 2021 Buy 50 000 Desai Meera J. Stock Appreciation Right
Show all Insider Trades


Last 100 transactions
Buy: 2 005 439 | Sell: 1 075 013 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 0.74 4.07 %
0.74 2.76 %
0.73 1.96 %
Current price: 0.72
Support 0.71 -0.66 %
0.70 -1.47 %
0.70 -2.78 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 0.81 12.79 %
0.75 4.85 %
0.73 2.15 %
Current price 0.72
Support 0.71 -0.28%
0.69 -3.52%
0.68 -4.68%

Click to get the best stock tips daily for free!

About Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, engages in developing and commercializing products in the therapeutic areas of allergy and respiratory disease. Its specialty pharmaceutical product candidates include the Epinephrine Injection PFS syringe product for use in the emergency treatment of anaphylaxis; APC-1000 and APC-5000 for the treatment of asthma and chronic obstructive pulmonary disease; and APC-2000 for ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE